EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma

Hourin Cho, Kouya Shiraishi, Kuniko Sunami, Yukihide Momozawa, Tatsuya Yoshida, Shingo Matsumoto, Koichi Matsuda, Motonobu Saito, Akiteru Goto, Takayuki Honda, Akifumi Mochizuki, Masahiro Torasawa und 48 weitere

Journal of Thoracic Oncology · 2025

DOI: 10.1016/j.jtho.2025.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Oncology, 2025. Verfasst von Hourin Cho und 59 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. Hauptthemen laut MEDLINE: Germ-Line Mutation, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BRIDGE (programs for bridging the gap between R&D and the ideal society, National cancer center research and development fund, Core Research for Evolutional Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Up to 54% of all lung adenocarcinoma (LADC) cases in Asian populations occur in never-smoking women, suggesting that the impact of smoking and other environmental factors on the risk of early-onset LADC is minimal. Genetic factors may play a crucial role in disease development. METHODS: The prevalence of germline pathogenic variants (GPVs) of 454 hereditary cancer and DNA repair genes was evaluated by whole-exome and whole-genome sequencing of 348 early-onset LADC (aged ≤ 40 y) and 1425 later-onset LADC (aged ≥ 41 y) cases. A case-control study comprising 10,302 LADC cases and 7898 healthy controls was performed to identify moderate-risk genetic factors for the disease. Analysis of somatic mutations in 1278 patients with LADC, including 31 patients with GPVs, was also performed. RESULTS: The frequency of GPVs of TP53 and BRCA2 was significantly higher in those with early-onset LADC than in those with later-onset LADC. The detection rates for TP53 and BRCA2 GPVs were 2.9% and 1.7%, respectively, in patients with early-onset LADC, and 0.14% and 0.21%, respectively, in patients with later-onset LADC. Patients with BRCA1 GPVs exhibited a high incidence of concurrent TP53 somatic mutations. Patients with BRCA2 GPVs exhibited deficient homologous recombination in tumors by means of loss of the wild-type allele. A germline ALKBH2 variant, p.Glu35Alafs∗54, was associated with the risk of early-onset LADC, and patients with a deleterious variant exhibited a correlation between SBS4-related somatic mutations and the Brinkman index. CONCLUSION: TP53 and BRCA2 GPVs and the ALKBH2 novel variant are associated with early-onset LADC in Asians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationLung NeoplasmsAdenocarcinoma of LungHumansFemaleMaleAdultCase-Control StudiesMiddle AgedGenetic Predisposition to DiseaseAgedPenetranceAge of OnsetBRCA2 ProteinPrognosis

Stichwörter der Autor:innen

ALKBH2BRCA2Early-onsetHereditaryLung adenocarcinomaTP53

Substanzen

BRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan. Electronic address: kshirais@ncc.go.jp.
  • Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Science, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

Förderung

  • BRIDGE (programs for bridging the gap between R&D and the ideal society
  • National cancer center research and development fund
  • Core Research for Evolutional Science and Technology
  • Japan Society for the Promotion of Science
  • Universita degli Studi del Piemonte Orientale Amedeo Avogadro
  • National Cancer Coalition
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency

Zitieren

APA

Cho, H., Shiraishi, K., Sunami, K., Momozawa, Y., Yoshida, T., Matsumoto, S., Matsuda, K., Saito, M., Goto, A., Honda, T., Mochizuki, A., Torasawa, M., Daigo, Y., Shimizu, K., Kunitoh, H., Yoshida, Y., Hirata, M., Shimada, Y., Ueki, M., …, & Inazawa, J. (2025). Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2025.06.005

Vancouver

Cho H, Shiraishi K, Sunami K, Momozawa Y, Yoshida T, Matsumoto S, et al. Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma. Journal of Thoracic Oncology. 2025. doi:10.1016/j.jtho.2025.06.005

BibTeX
@article{Cho2025,
  author = {Cho, Hourin and Shiraishi, Kouya and Sunami, Kuniko and Momozawa, Yukihide and Yoshida, Tatsuya and Matsumoto, Shingo and Matsuda, Koichi and Saito, Motonobu and Goto, Akiteru and Honda, Takayuki and Mochizuki, Akifumi and Torasawa, Masahiro and Daigo, Yataro and Shimizu, Kimihiro and Kunitoh, Hideo and Yoshida, Yukihiro and Hirata, Makoto and Shimada, Yoko and Ueki, Michiko and Ono, Hanako and Gotoh, Masahiro and Shimoda Igawa, Yukiko and Tateishi, Akiko and Yamaguchi, Yoh and Inaba Higashiyama, Ryoko and Machida, Erika and Iwasaki, Motoki and Kawai, Yosuke and Yasuda, Hiroyuki and Hamamoto, Junko and Imoto, Issei and Matsushita, Hirokazu and Takata, Sadaaki and Aoi, Tomomi and Kaneko, Syuzo and Kuchiba, Aya and Shimomura, Akihiko and Fukami, Maki and Hattori, Kotaro and Ozaki, Kouichi and Asano, Yoshihiro and NCBN Controls WGS Consortium, NCBN Controls WGS Consortium and Biobank Japan Project, Biobank Japan Project and Takano, Atsushi and Kobayashi, Masashi and Miyagi, Yohei and Tanaka, Kazumi and Suzuki, Hiroyuki and Yamaura, Takumi and Yoshida, Teruhiko and Goto, Yasushi and Horinouchi, Hidehito and Miyazaki, Yasunari and Ito, Hidemi and Nagashima, Toshiteru and Ohtaki, Yoichi and Imai, Kazuhiro and Minamiya, Yoshihiro and Okubo, Kenichi and Inazawa, Johji},
  title = {Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma},
  journal = {Journal of Thoracic Oncology},
  year = {2025},
  doi = {10.1016/j.jtho.2025.06.005}
}
Kostenlos starten →